Physician profile
David C Gordon
NPI 1215949946
$910.13
in general payments reported to CMS, 2019-2025
11 companies · $65.80 in 2025
The $65.80 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $239 · 2021: $151 · 2022: $14.06 · 2023: $118 · 2024: $82.06 · 2025: $65.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $265.14 | 2019-2021 | |
| Aerin Medical INC. | $135.12 | 2023-2024 | |
| Intersect Ent, INC. | $131.98 | 2020-2021 | |
| Glaxosmithkline, LLC. | $87.77 | 2021 | |
| Acclarent, INC | $74.50 | 2020 | |
| Integra Lifesciences Corporation | $64.67 | 2024 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Genzyme Corporation | $54.51 | 2019-2020 | |
| Medtronic, INC. | $33.05 | 2022-2025 | Pteye Parathyroid Detection System |
| Baxter Healthcare | $29.18 | 2025 | Perclot |
| Vertex Pharmaceuticals Incorporated | $17.63 | 2025 | |
| Optinose US, INC. | $16.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.